MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
*Funding: Surgery_Surgical Technology, Minimally Invasive & Operating Room of the Future (ORF)
*Venture Capital Companies: Life Science, Health IT & Healthcare Investors
ARCH Venture Partners - (#8 Healthcare Investor 2013) WBT
Finance & Acquisitions: Arch Ventures
*Portfolio Companies: Arch Ventures
Seredigm
Parents
*Architects: BioPharmaceuticals_Inflammation, Allergy & Autoimmune
*Portfolio Companies: Arch Ventures
*Portfolio Companies: MPM Capital
*Portfolio Companies: Versant
Amgen Ventures
Architects: Biotechnology_Proteomics
Children
*Portfolio Companies: Accelerator Corporation
*Portfolio Companies: OVP
Dr John Harlan
Dr Robert Winn
prevent apoptosis & organ damage following shock
Protein based drug development
Shut down inflammatory and immunological response
Jumps
Apoptosis
CCC: Science & Technology Objectives
Fiona Willis, Licensing Officer, U of W
Protein and Gene Regulatory Networks
University of Washington